IBM today announced IBM Power Autonomous Operations, an AI agent that can help continuously monitor Power systems and autonomously resolve issues to keep operations running smoothly. It complements ...
The AI buildout is usually described in one word: chips. But the more revealing story may be happening downstream in the specialty automation, robotics and semiconductor production equipment needed to ...
The US Food and Drug Administration (FDA) has approved two of Merck & Co's (MSD) Keytruda (pembrolizumab) and Keytruda Qlex ...
The platinum-free combination significantly improved EFS, OS, and pathologic complete response rates compared with standard neoadjuvant gemcitabine/cisplatin.
On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE and Astellas Pharma Inc.’s ALPMF ALPMY ...
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...
Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall Street Journal. The move bolsters Merck’s pipeline with the COPD drug ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results